DK0965644T3 - Ligander til modulering af ekspression af eksogene gener via et ecdyson receptorkompleks - Google Patents

Ligander til modulering af ekspression af eksogene gener via et ecdyson receptorkompleks

Info

Publication number
DK0965644T3
DK0965644T3 DK99304444T DK99304444T DK0965644T3 DK 0965644 T3 DK0965644 T3 DK 0965644T3 DK 99304444 T DK99304444 T DK 99304444T DK 99304444 T DK99304444 T DK 99304444T DK 0965644 T3 DK0965644 T3 DK 0965644T3
Authority
DK
Denmark
Prior art keywords
ligands
receptor complex
response element
exogenous genes
ligand
Prior art date
Application number
DK99304444T
Other languages
Danish (da)
English (en)
Inventor
Robert Eugene Hormann
Dat Phat Le
Glenn Richard Carlson
Dean Ervin Cress
Tarlochan Singh Dhadialla
Original Assignee
Intrexon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrexon Corp filed Critical Intrexon Corp
Application granted granted Critical
Publication of DK0965644T3 publication Critical patent/DK0965644T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99304444T 1998-06-17 1999-06-08 Ligander til modulering af ekspression af eksogene gener via et ecdyson receptorkompleks DK0965644T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8954698P 1998-06-17 1998-06-17
US09/315,451 US6258603B1 (en) 1998-06-17 1999-05-02 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

Publications (1)

Publication Number Publication Date
DK0965644T3 true DK0965644T3 (da) 2008-01-28

Family

ID=26780689

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99304444T DK0965644T3 (da) 1998-06-17 1999-06-08 Ligander til modulering af ekspression af eksogene gener via et ecdyson receptorkompleks

Country Status (14)

Country Link
US (2) US6258603B1 (fr)
EP (1) EP0965644B1 (fr)
JP (1) JP4537512B2 (fr)
KR (1) KR100563143B1 (fr)
CN (1) CN1296480C (fr)
AT (1) ATE378414T1 (fr)
AU (1) AU765306B2 (fr)
BR (1) BR9902283A (fr)
CY (1) CY1107083T1 (fr)
DE (1) DE69937519T2 (fr)
DK (1) DK0965644T3 (fr)
ES (1) ES2296370T3 (fr)
PT (1) PT965644E (fr)
TW (1) TWI224109B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875727B2 (en) * 1997-12-23 2005-04-05 Syngenta Crop Protection, Inc. Use of macrolides in pest control
AUPP135698A0 (en) 1998-01-15 1998-02-05 Commonwealth Scientific And Industrial Research Organisation Insectical modalities
AU2001241682A1 (en) * 2000-02-24 2001-09-03 The Salk Institute For Biological Studies Gene expression system based on chimeric receptors
US20040033600A1 (en) * 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
JP5031967B2 (ja) 2000-03-22 2012-09-26 イントレキソン コーポレーション 新規エクジソン受容体ベースの誘導性遺伝子発現系
US8105825B2 (en) * 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
US6576422B1 (en) 2000-10-17 2003-06-10 Rohm And Haas Company Method for identifying products employing gene expression
WO2002066613A2 (fr) * 2001-02-20 2002-08-29 Rheogene Holdings, Inc Nouveau systeme d'expression genetique inductible base sur le recepteur d'ecdysone/recepteur de retinoide x invertebre
CA2438133C (fr) 2001-02-20 2015-01-27 Rheogene, Inc. Nouveaux recepteurs a mutant de substitution et utilisation de ceux-ci dans un systeme d'expression de gene inductible fonde sur un recepteur nucleaire
EP1373470B1 (fr) * 2001-02-20 2013-04-24 Intrexon Corporation Nouveaux recepteurs de mutants de substitution et utilisation de ceux-ci dans un systeme d'expression genique inductible a base de recepteurs nucleaires
ES2424812T3 (es) * 2001-02-20 2013-10-08 Intrexon Corporation Receptores X retinoides quiméricos y su uso en un sistema inducible de expresión génica basado en receptores de ecdisona novedoso
WO2003027289A1 (fr) 2001-09-26 2003-04-03 Rheo Gene Holdings, Inc. Acides nucleiques du recepteur a l'ecdysone de la cicadelle, polypeptides, et utilisation de ceux-ci
GB2387599B (en) * 2002-04-17 2005-08-10 Jason Peter Brown Methods for producing antibodies
US20050228016A1 (en) * 2002-06-13 2005-10-13 Enrique Michelotti Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US7375093B2 (en) 2002-07-05 2008-05-20 Intrexon Corporation Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US8076318B2 (en) * 2002-10-24 2011-12-13 Albert Einstein College Of Medicine Of Yeshiva University Caged ligands and uses thereof
AU2011202682B2 (en) * 2003-02-10 2013-11-28 Intrexon Corporation Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7304161B2 (en) * 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7304162B2 (en) * 2003-02-21 2007-12-04 Intrexon Corporation Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7456315B2 (en) * 2003-02-28 2008-11-25 Intrexon Corporation Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7425700B2 (en) * 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
US20050164210A1 (en) * 2004-01-23 2005-07-28 Vivek Mittal Regulated polymerase III expression systems and related methods
US7935510B2 (en) 2004-04-30 2011-05-03 Intrexon Corporation Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
US8115059B1 (en) 2005-07-22 2012-02-14 University Of Kentucky Research Foundation Gene expression modulation system for use in plants and method for modulating gene expression in plants
CN104761466A (zh) 2007-05-29 2015-07-08 英特拉克森公司 通过蜕皮素受体复合物调节外源性基因表达的手性二酰基肼配体
WO2009025866A1 (fr) 2007-08-23 2009-02-26 Intrexon Corporation Procédés et compositions de diagnostic d'une maladie
BRPI0817009A2 (pt) * 2007-09-17 2014-10-07 Rohm & Haas Sistema de expressão de gene para a expressão controlável de resposta ao etileno em uma célula de planta, composição, e, métodos para produzir uma planta transgênica, e para modular sensibilidade ao etileno em uma planta.
KR101666228B1 (ko) 2007-09-28 2016-10-13 인트렉손 코포레이션 생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도
HUE035406T2 (en) 2007-10-08 2018-05-02 Intrexon Corp Engineered dendritic cells and uses for the treatment of cancer
EP2265116A4 (fr) 2008-03-14 2013-02-06 Intrexon Corp Ligands stéroïdes et leur utilisation dans la modulation de la commutation génique
MX2011009239A (es) 2009-03-05 2011-09-15 Rohm & Haas Control de rotacion apuntada de proteina de ruta de señalizacion de hormona de etileno clave para modular la sensibilidad a etileno en plantas.
CA2794196A1 (fr) 2010-03-23 2011-09-29 Intrexon Corporation Vecteurs exprimant des proteines therapeutiques de maniere conditionnelle, cellules hotes comprenant les vecteurs, et utilisations associees
SG10201600912SA (en) 2011-03-04 2016-03-30 Intrexon Corp Vectors conditionally expressing protein
EP2699688A1 (fr) 2011-04-20 2014-02-26 The Trustees Of The University Of Pennsylvania Régimes et compositions pour l'immunisation passive médiée par aav contre des agents pathogènes en suspension dans l'air
ES2683329T3 (es) 2013-03-15 2018-09-26 Intrexon Corporation Diacilhidrazinas que contienen boro
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
WO2016044390A1 (fr) 2014-09-17 2016-03-24 Intrexon Corporation Composés diacylhydrazine contenant du bore
EA201792500A1 (ru) 2015-05-13 2018-04-30 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Aav-опосредованная экспрессия антител против гриппа и способы их использования
UY37343A (es) 2016-07-25 2018-02-28 Intrexon Corp Control del fenotipo en plantas
CN110139933B (zh) 2016-11-09 2024-03-08 英特瑞克斯顿股份有限公司 共济蛋白表达构建体
JP7455579B2 (ja) 2017-02-28 2024-03-26 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 新規アデノ随伴ウイルス(aav)クレードfベクター及びその用途
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
CA3052487A1 (fr) 2017-02-28 2018-09-07 The Trustees Of The University Of Pennsylvania Vaccins contre la grippe bases sur des vecteurs aav
TW202237850A (zh) 2020-12-01 2022-10-01 賓州大學委員會 具有組織特異性靶向基序的新穎構成物及含有其之組成物
AR125406A1 (es) 2021-04-23 2023-07-12 Univ Pennsylvania Nuevas composiciones con motivos selectivos para el cerebro y composiciones que las contienen
EP4409010A1 (fr) 2021-10-02 2024-08-07 The Trustees of The University of Pennsylvania Nouvelles capsides de vaa et compositions les contenant
US20250144243A1 (en) 2022-01-25 2025-05-08 The Trustees Of The University Of Pennsylvania Aav capsids for improved heart transduction and detargeting of liver
KR20250135916A (ko) 2022-12-17 2025-09-15 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 심장 및 골격근 특이적 표적화 모티프를 갖는 재조합 aav 돌연변이체 벡터 및 이를 포함하는 조성물
WO2024130070A2 (fr) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Capsides aav recombinantes avec motifs de ciblage spécifiques du muscle cardiaque et squelettique et leurs utilisations
AR133098A1 (es) 2023-06-29 2025-08-27 Univ Pennsylvania Aav mutante con motivos dirigidos al sistema nervioso central y composiciones que lo contienen
WO2025102034A1 (fr) 2023-11-10 2025-05-15 The Trustees Of The University Of Pennsylvania Thérapie génique pour le syndrome de barth
WO2025106661A1 (fr) 2023-11-14 2025-05-22 The Trustees Of The University Of Pennsylvania Compositions ayant des motifs de ciblage spécifiques des muscles cardiaques et squelettiques et leurs utilisations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5117057A (en) * 1985-10-21 1992-05-26 Rohm And Haas Company Insecticidal N' substituted-N-N'-disubstituted-hydrazines
US5530028A (en) * 1992-11-23 1996-06-25 Rohm And Haas Company Insecticidal N'-substituted-N,N'-diacylhydrazines
US5344958A (en) * 1992-11-23 1994-09-06 Rohm And Haas Company Insecticidal N'-substituted-N,N'-diacylhydrazines
JP4004555B2 (ja) * 1993-09-29 2007-11-07 ダウ アグロサイエンシィズ エルエルシー 殺虫化合物
US5482962A (en) * 1994-07-22 1996-01-09 Rohm And Haas Company Insecticidal N,N'-disubstituted-N-N'-diacylhydrazines
ATE293699T1 (de) * 1995-03-03 2005-05-15 Syngenta Participations Ag Kontrolle der pflanzengenexpression durch rezeptor-vermittelte transaktivation in gegenwart von einem chemischen ligand
CA2219121A1 (fr) * 1995-05-26 1996-11-28 Zeneca Limited Commutateur de gene comprenant un recepteur d'ecdysone
AU734051B2 (en) * 1996-04-05 2001-05-31 Salk Institute For Biological Studies, The Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
US6333318B1 (en) * 1998-05-14 2001-12-25 The Salk Institute For Biological Studies Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
AU5915999A (en) * 1998-09-10 2000-04-03 Pioneer Hi-Bred International, Inc. Ecdysone receptors and methods for their use

Also Published As

Publication number Publication date
EP0965644B1 (fr) 2007-11-14
KR100563143B1 (ko) 2006-03-22
JP2000037189A (ja) 2000-02-08
EP0965644A3 (fr) 2004-01-07
EP0965644A2 (fr) 1999-12-22
JP4537512B2 (ja) 2010-09-01
US20010044151A1 (en) 2001-11-22
ES2296370T3 (es) 2008-04-16
CY1107083T1 (el) 2012-10-24
TWI224109B (en) 2004-11-21
BR9902283A (pt) 2000-05-02
PT965644E (pt) 2007-12-03
AU3390099A (en) 2000-02-10
DE69937519D1 (de) 2007-12-27
ATE378414T1 (de) 2007-11-15
KR20000006256A (ko) 2000-01-25
AU765306B2 (en) 2003-09-18
CN1296480C (zh) 2007-01-24
DE69937519T2 (de) 2008-09-04
US6258603B1 (en) 2001-07-10
CN1251389A (zh) 2000-04-26

Similar Documents

Publication Publication Date Title
DK0965644T3 (da) Ligander til modulering af ekspression af eksogene gener via et ecdyson receptorkompleks
MXPA04012391A (es) Tetrahidroquinolinas para modular la expresion de genes exogenos a traves de un complejo receptor de ecdisona.
MXPA05000274A (es) Ligandos de cetona para modular la expresion de genes exogenos a traves de un complejo receptor de ecdisona.
DE69809034D1 (de) System zum eingeben von tastaturkanaldaten zur programmquellenselektion
EP0770129A4 (fr) Derives de proteine a doigts zinciques et procedes associes
DE59810783D1 (de) Hub- und Tiefensteuersystem für Anbaugeräte
ATE309536T1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DE69637259D1 (de) OFDM Kommunikationsgeräte unter Verwendung von pseudo-zufällig modulierten Referenzsymbolen
DE69929524D1 (de) Oligonukleotide mit für bindungstaschen spezifischen chiralen phosphorothioat-internukleosidbindungen
DE122005000013I1 (de) Triacetin zur Erhöhung der transdermalen Penetration.
DE69532582D1 (de) Biologische bekämpfung von insekten
ATE364696T1 (de) Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
DE68913658D1 (de) Klonierung von Immunglobulin sequenzen aus den variabelen Domänen.
DE69824693D1 (de) Ruthenium-Metathesekatalysator und Verfahren zur Olefinmetathese unter Verwendung des Katalysators
ATE271532T1 (de) Hydroformylierung von olefinen unter verwendung von bis(phosphor) trägerliganden
DE19882911T1 (de) Verwendung von Macroliden bei der Schädlingsbekämpfung
DE69828015D1 (de) Verarbeitungsanordnung und System zur Aktualisierung von Betriebssteuerungsinformationen unter Verwendung der Verarbeitungsanordnung
DE69512772D1 (de) Methode zur kontrolle der dichte von an trägern gebundenen liganden und danach hergestellte produkte.
DK0927252T3 (da) Antistoffer mod interferon-alfa-/beta-receptor
DE69839527D1 (de) System zum analysieren von kontrollierfunktion
DE19982478T1 (de) Verwendung von Insektiziden zur Schädlingsbekämpfung
DE69823372T8 (de) Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen
DE69818773D1 (de) Kommunikationsvorrichtung, Kommunikationsverfahren und Aufzeichnungsmedium mit dem Rechnerprogramm zur Durchführung des Verfahrens
ATE301192T1 (de) Verwendung von neuronalem apoptose- inhibitorprotein
DE60008118D1 (de) Dampfphasencarbonylierungsverfahren unter verwendung von aktivierten iridium-katalysatoren